Results 81 to 90 of about 2,709 (130)

Neurologic Adverse Events Associated with Voriconazole Therapy: Report of Two Pediatric Cases

open access: yesCase Reports in Infectious Diseases, 2016
Although voriconazole, a triazole antifungal, is a safe drug, treatment with this agent is associated with certain adverse events such as hepatic, neurologic, and visual disturbances.
Sevliya Öcal Demir   +7 more
doaj   +1 more source

The Global Antifungal Susceptibility Epidemiology of Trichophyton indotineae Indicating Voriconazole as an Alternative Therapy for Recalcitrant Dermatophytosis

open access: yesMycoses, Volume 69, Issue 6, June 2026.
ABSTRACT Background The emergence of Trichophyton indotineae as a multidrug‐resistant dermatophyte has challenged conventional therapeutic approaches for dermatophytosis, leading to a significant therapeutic dilemma. The absence of formal epidemiological cutoff values (ECVs) under the Clinical and Laboratory Standards Institute (CLSI) framework has led
Ge Song   +5 more
wiley   +1 more source

Comparison of DermaGenius and In‐House qPCR Methods for Detection of Recalcitrant Dermatophyte Infections: A Practical Approach for Dermatologists and Mycologists

open access: yesMycoses, Volume 69, Issue 6, June 2026.
ABSTRACT Background Chronic and recalcitrant dermatophytosis has become increasingly problematic in dermatology practice, largely due to emerging antifungal resistance, affecting not only terbinafine but also azoles. Among the causative agents, Trichophyton indotineae has emerged as a key pathogen associated with treatment failure, extensive disease ...
Murat Durdu   +8 more
wiley   +1 more source

Surgical Outcomes and Exploratory Preoperative Risk Stratification for Invasive Pulmonary Fungal Infections in Paediatric Patients: A Single‐Center Retrospective Study

open access: yesMycoses, Volume 69, Issue 6, June 2026.
ABSTRACT Background Invasive pulmonary fungal infections (IPFIs) in immunocompromised children carry high morbidity and may interrupt life‐saving chemotherapy or haematopoietic stem cell transplantation (HSCT). Evidence on perioperative risk stratification for surgical management is limited.
Gang Yang   +6 more
wiley   +1 more source

Influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

open access: yesBMC Pediatrics
Purpose We aimed to investigated the influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Methods This was a prospective cohort design study.
Ting Zhao   +6 more
doaj   +1 more source

A Retrospective, Comparative Cohort Analysis of the Utilization of Voriconazole-Containing Regimens Versus Itraconazole in the Treatment of Blastomycosis

open access: yesJournal of Fungi
Itraconazole is the recommended first-line antifungal agent in blastomycosis treatment. However, pharmacokinetic limitations and adverse drug events may necessitate the use of alternative antifungal agents.
Caitlin C. Schanz   +8 more
doaj   +1 more source

The Effect of Rifapentine and Rifampicin on Serum Voriconazole Levels Persist for 5 Days and 7 Days or More After Discontinuation in Tuberculosis Patients with Chronic Pulmonary Aspergillosis

open access: yesInfection and Drug Resistance
Hong Lu,* Yanmei Mao,* Ying Zeng, Pengyu Li, Pan Yan, Qunzhi Shi, Lin Liu Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, People’s Republic of China*These ...
Lu H   +6 more
doaj  

Voriconazole-Induced acute interstitial pulmonary edema with angioedema: A case report

open access: yesBMC Pulmonary Medicine
Background Voriconazole is a first-line antifungal agent for invasive fungal infections. Reports of voriconazole-induced interstitial pulmonary edema are exceedingly rare.
Yuzhen Jin   +4 more
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy